Rotavirus vaccine Interactions
Showing entire list of all interactions, including brand names and combination drugs.
Go back to interactions summary
Medications known to interact with rotavirus vaccine
P
- paclitaxel
- paclitaxel protein-bound
- pacritinib
- Padcev (enfortumab vedotin)
- palbociclib
- Panglobulin (immune globulin intravenous)
- Panglobulin NF (immune globulin intravenous)
- panobinostat
- Panzyga (immune globulin intravenous)
- Paraplatin (carboplatin)
- Partobulin SDF (rho (d) immune globulin)
- pazopanib
- PediaPred (prednisolone)
- pegaspargase
- pemetrexed
- Pemfexy (pemetrexed)
- Pemrydi RTU (pemetrexed)
- pentostatin
- Pepaxto (melphalan flufenamide)
- Pfizer-BioNTech COVID-10 (6m-4y) Vaccine PF (sars-cov-2 mrna (tozinameran 6m-4y) vaccine)
- Pfizer-BioNTech COVID-19 (12y+) Bivalent Booster Vaccine PF (sars-cov-2 (covid-19) mrna (tozinameran 12y+) bivalent booster vaccine)
- Pfizer-BioNTech COVID-19 (12y+) Bivalent Vaccine PF (sars-cov-2 (covid-19) mrna(tozinameran12y+) bivalent vaccine)
- Pfizer-BioNTech COVID-19 (2023-2024) Vaccine PF (cvx 308) (sars-cov-2 (covid-19) mrna-lnp vaccine (cvx 308))
- Pfizer-BioNTech COVID-19 (2023-2024) Vaccine PF (cvx 310) (sars-cov-2 (covid-19) mrna-lnp vaccine (cvx 310))
- Pfizer-BioNTech COVID-19 (5y-11y) Bivalent Booster Vaccine PF (sars-cov-2 (covid-19) mrna (tozinameran 5y-11y) bivalent booster vaccine)
- Pfizer-BioNTech COVID-19 (5y-11y) Bivalent Vaccine PF (sars-cov-2(covid-19)mrna(tozinameran 5y-11y)bivalent vaccine)
- Pfizer-BioNTech COVID-19 (5y-11y) Vaccine PF (sars-cov-2 mrna (tozinameran 5y-11y) vaccine)
- Pfizer-BioNTech COVID-19 (6m-4y) Bivalent Booster Vaccine PF (sars-cov-2 (covid-19) mrna (tozinameran 6m-4y) bivalent booster vaccine)
- Pfizer-BioNTech COVID-19 (6m-4y) Bivalent Vaccine PF (sars-cov-2 (covid-19) mrna (tozinameran 6m-4y) bivalent vaccine)
- Pfizer-BioNTech COVID-19 (6m-4y) Vaccine PF (sars-cov-2 mrna (tozinameran 6m-4y) vaccine)
- Pfizer-BioNTech COVID-19 Vaccine (Do Not Dilute) (sars-cov-2 mrna (tozinameran-tris-sucrose) vaccine)
- Pfizer-BioNTech COVID-19 Vaccine (sars-cov-2 mrna (tozinameran) vaccine)
- Pharmorubicin PFS (epirubicin)
- Pharmorubicin RDF (epirubicin)
- Phesgo (hyaluronidase / pertuzumab / trastuzumab)
- Phyrago (dasatinib)
- pirtobrutinib
- Platinol (cisplatin)
- Platinol-AQ (cisplatin)
- plicamycin
- Pluvicto (lutetium lu 177 vipivotide tetraxetan)
- polatuzumab vedotin
- Polivy (polatuzumab vedotin)
- Polygam S/D (immune globulin intravenous)
- pomalidomide
- Pomalyst (pomalidomide)
- ponatinib
- ponesimod
- Ponvory (ponesimod)
- Poteligeo (mogamulizumab)
- pralatrexate
- Pred-Ject-50 (prednisolone)
- Predacort 50 (prednisolone)
- Predacorten (methylprednisolone)
- Predaject-50 (prednisolone)
- Predalone 50 (prednisolone)
- Predate-50 (prednisolone)
- Predcor (prednisolone)
- Predicort RP (prednisolone)
- Predicort-50 (prednisolone)
- Prednicen-M (prednisone)
- Prednicot (prednisone)
- prednisolone
- prednisone
- Prelone (prednisolone)
- Pri-Cortin 50 (prednisolone)
- Primethasone (dexamethasone)
- Privigen (immune globulin intravenous)
- procarbazine
- Prograf (tacrolimus)
- Proleukin (aldesleukin)
- Pulmicort Flexhaler (budesonide)
- Pulmicort Nebuamp (budesonide)
- Pulmicort Respules (budesonide)
- Pulmicort Turbuhaler (budesonide)
- Purinethol (mercaptopurine)
- Purixan (mercaptopurine)
- Pyzchiva (ustekinumab)
More about rotavirus vaccine
- rotavirus vaccine consumer information
- Check interactions
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: viral vaccines
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.